ArticleOpen medicine (Warsaw, Poland)2026

Targeting ORM1-CCR5 axis inhibits the aggressive phenotype of synovial fibroblasts and alleviates RA.

Min Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.